US74766Q1013 - Common Stock
Several medtech companies are expected to release financial updates this coming week when the huge annual JP Morgan Healthcare Conference convenes in SF. Read more here here.
Although the weather might be chilly, a hot November happens to be a recurring theme, which may boost these stocks to buy.
Canaccord Genuity said it sees Quanterix (QTRX), Guardant Health (GH), Natera (NTRA) and PacBio (PACB) as attractive investments in the wake of a recent medtech sell-off.
Quanterix Corporation partners with a unit of Johnson & Johnson, to develop blood-based tests for Alzheimer's disease detection. Read more here.
Quanterix (QTRX) disclosed on Monday that director William Donnelly bought 20.2K common shares at $24.8504/share.Shares of QTRX rose 5.2% on Tuesday.